Back to search

Article

Real-world experience: Effect of Apixaban on INR, More confusion to providers with inadvertent lab

2023-04-10

Abstract excerpt

<h4>Background: </h4> Factor X inhibition can cause the prolongation of PT by acting on the common pathway factors. Although, Expensive and less available “calibrated anti-FXa” predicts DOAC plasma level had better than prothrombin time (PT) and the international normalized ratio (INR). Consecutive reports raise more attention to (PT/INR) abnormalities in clinical scenarios for the minority of patients on DOACs. T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32387b72-509d-53d7-85b0-e351f717f5e7
DOI
10.21203/rs.3.rs-2687274/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world experience: Effect of Apixaban on INR, More confusion to providers with inadvertent labDOI 10.21203/rs.3.rs-2687274/v1
Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?Semantic proximity
Investigating unexpected INRs: in search of the culprit--adherence, interactions, genetics, and superwarfarin.Semantic proximity
Hemostatic Profiling of Generic Factor Xa Inhibitors Using ROTEM® Viscoelastometry and Multimodal Coagulation Assays: A Real-World Study in a Tunisian CohortSemantic proximity
Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era.Semantic proximity
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingSemantic proximity
An ADR pharmaceutical care for severe gastrointestinal bleeding of rivaroxaban in a patient with non-valvular atrial fibrillation based on TDM and genetic testingSemantic proximity
Comparable Outcomes Using Low-Dose Apixaban and Anti-Xa Monitoring and Vitamin-K Antagonists in Patients with Renal Replacement TherapySemantic proximity
Variations in prothrombin time-international normalized ratio caused by drug-drug interaction in patients receiving warfarin: A retrospective observational study.Semantic proximity
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesSemantic proximity
Predictors of Anticoagulant Treatment Control in New Warfarin Patients in JordanSemantic proximity
Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.Semantic proximity
Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.Semantic proximity
Select a neighboring publication to make it the new centre.